Découvrez les posters présentés par OPM !
AACR 2024 :
- “Unlocking the Potential of OPM-383: A Novel LRRK2 Inhibitor in Cancer Therapy”
Auteurs: Maria Eugenia Riveiro, Petra Blom, Kenji Shoji, Jan Hoflack
Oncodesign Precision Medicine S.A., Dijon, France
- “OPM-116, a highly potent and specific PI3Kγ inhibitor to enhance antitumor immunity”
Auteurs: Kenji F. Shoji, Oleksandr Levenets, Petra Blom, Maria Eugenia Riveiro, Jan Hoflack
Oncodesign Precision Medicine S.A., Dijon, France
IBD 2024 :